how many people are using glp-1 Poll: 1 in 8 Adults Say They Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford The Evolution of GLP-1 Users
Description
Well help you take realistic, meaningful steps forward
Understanding Semaglutide Semaglutide is a groundbreaking FDA-approved GLP-1 receptor agonist designed for chronic weight management in individuals with obesity or those overweight with at least one weight-related medical condition
As of 2024, only about 13 states cover GLP-1s for obesity under Medicaid
The average score was 5.4, with similar numbers of respondents on each side of the scale
You can also order your own blood tests if you want to do a fasting blood glucose test from a lab, perhaps as a way of double-checking the accuracy of your meter
Retatrutide is an investigational medication that works differently
